Source: International Congress 2019 – Pulmonary hypertension: clinical
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Sahay (Houston, United States of America), Y. Tsang (South San Francisco, United States of America), M. Flynn (South San Francisco, United States of America), R. Dufour (South San Francisco, United States of America), W. Drake (South San Francisco, United States of America). Impact of pulmonary hypertension (PH) on healthcare resource utilization and costs in patients with portal hypertension. 4747

Member's Comments

No comment yet.

Related content which might interest you: Impact of initiation of sildenafil on patterns of healthcare utilization and cost in patients with pulmonary arterial hypertension (PAH) Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010 Optimising the management of pulmonary arterial hypertension patients: emergency treatments Source: Eur Respir Rev 2010 19: 204-211 Year: 2010 Impact of pulmonary arterial hypertension (PAH) on the lives of patients and carers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Predictors of high utilization of health care services in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 25s Year: 2001 Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019 Critical care admissions in patients with pulmonary arterial hypertension. Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Characteristics of patients treated for pulmonary arterial hypertension in real-world database representing a large US health plan Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019 Evaluating health care resource consumption in chronic obstructive pulmonary disease (COPD) patients (VICE Study) Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006 Improving patient outcomes in pulmonary hypertension Source: Eur Respir Rev 2015; 24: 550-551 Year: 2015 Trends in healthcare utilization and costs prior to a chronic obstructive pulmonary disease (COPD) diagnosis Source: Eur Respir J 2006; 28: Suppl. 50, 36s Year: 2006 An international survey of current pulmonary arterial hypertension (PAH) management Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments Year: 2012 Blending pulmonary rehabilitation into the WHO view of integrated care Source: Annual Congress 2005 - The ERS/ATS statements on pulmonary rehabilitation Year: 2005 Impact of integrated care on health status in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 377s Year: 2002 Integrated care prevents hospitalisations for exacerbations in COPD patients Source: Eur Respir J 2006; 28: 123-130 Year: 2006 The changing landscape of pulmonary arterial hypertension and implications for patient care Source: Eur Respir Rev 2014; 23: 450-457 Year: 2014 Clinical characteristics of the pulmonary hypertension (PH) in a cardiologist service Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 Hospitalization in patients with pulmonary arterial hypertension: causes and outcomes Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Identifying chronic thromboembolic pulmonary hypertension (CTEPH) through French national hospital database (PMSI) Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Geographical barriers in access to pulmonary arterial hypertension care in Brazilian public health system Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021